市場調查報告書
商品編碼
1197518
醫療連接器市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)Medical Connectors Market - Growth, Trends, and Forecasts (2023 - 2028) |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預測期內,醫療連接器市場的複合年增長率預計為 10.3%。
隨著 COVID-19 感染引起的大流行期間 COVID-19 患者和住院人數激增,COVID-19 大流行極大地擴大了醫療保健連接設備的使用。 此外,產能下降和供應鏈緩慢阻礙了 2020 年初的市場增長。 根據 2020 年 2 月的新聞稿,連接器供應商 Amphenol Corp. 報告稱,中國爆發的 COVID-19 疫情影響了其業務。 Amphenol 表示,預計將無法實現 2020 年第一季度的銷售目標。 儘管如此,自限制解除以來,該行業恢復良好,供應鏈在預測期內恢復正常。
促進醫療連接器市場增長的主要因素是自身免疫性疾病、癌症和血液病等慢性病發病率的上升。 越來越多的慢性病患者也推動了對醫療連接器的需求。 根據 GLOBOCAN 2020,2020 年全球將有 19,292,789 名新癌症患者和 9,958,133 名癌症相關死亡者。 在所有癌症中,2020 年乳腺癌新增病例為 2,261,419 例,其次是肺癌 2,206,771 例,前列腺癌 1,414,259 例,結腸癌 1,148,515 例。 因此,預計在預測期內,越來越多的慢性病將提振醫療連接器市場。
此外,幾個關鍵因素在將醫療連接器市場提升到一個新水平方面發揮著至關重要的作用。 這些因素,包括醫療連接器的技術進步和開拓,預計將推動醫療連接器市場的增長。 例如,2021 年 9 月,生產各種一次性連接器的 Dover's CPC(Colder Products Company)向生物製藥製造商宣布了一種新型微型無菌連接器,這是一種期待已久的低容量封閉無菌管焊替代方案過程.. MicroCNX 系列連接器是市場上首批開發的無菌連接器,旨在為小批量無菌工藝中的管焊接提供簡單高效的替代方案。
因此,上述所有因素都有望在預測期內提振市場。 然而,嚴格的監管標準可能會在預測期內抑制市場增長。
在小型和大型手術期間,患者監測設備用於監測患者的臨床症狀和相關並發症。 此外,由於無線技術的進步,這些設備可用於跟蹤患者的生理數據。 慢性病發病率和患病率的增加預計將推動該領域的增長。 這些設備旨在幫助醫生評估疾病的嚴重程度,因此在各種醫療機構中發揮著重要作用。 根據 2021 年 5 月發表在 Circulation Research 上的一篇論文,2020 年法國將有超過 100 萬人被診斷出患有心力衰竭 (HF),儘管治療管理良好,但仍有超過 15 萬例。我必須住院。 因此,預計慢性病患病率上升將在預測期內推動該領域的增長。
此外,預計在預測期內,產品批准的增加將提振市場。 例如,2022 年 8 月,Dozee 和在南亞生產病床和輔助家具方面具有優勢的 Midmark India 宣布了印度首個聯網技術,以自動化和集成病床中的患者監控,主要是在非 ICU 環境中。我們共同開發了床平台。
因此,上述所有因素都有望在預測期內推動該細分市場的增長。
在預測期內,預計北美將主導整個醫療連接器市場。 這在一定程度上是由於癌症、血液病和自身免疫性疾病等慢性病的發病率上升。 另一個主要因素是先進醫療基礎設施的發展。 在北美,由於癌症患者增加等因素,美國的市場份額最大。 另一個主要因素是市場參與者推出的產品。 例如,根據加拿大癌症協會的 2021 年報告,預計 2021 年加拿大將新增約 229,200 例癌症病例。 平均每天有 628 名加拿大人被診斷出患有癌症,預計還會有更多。 肺癌、乳腺癌、結直腸癌和前列腺癌是加拿大最常見的癌症類型(不包括非黑色素瘤皮膚癌)。 因此,預計該地區慢性病患病率的增加將支持市場的增長。
此外,市場參與者推出的產品有望推動市場增長。 例如,2022 年 10 月,Binder USA 推出了 570 系列易鎖連接器 (ELC),旨在滿足醫療設備使用的特定機電連接要求。 該連接器具有生物相容性,對皮膚無刺激性且耐消毒劑,因此非常適合在患者環境中使用。
因此,由於上述因素,北美地區有望在預測期內實現增長。
醫療連接器市場競爭適中,由幾家大型企業組成。 從市場份額的角度來看,一些主要參與者目前主導著市場。 一些主要參與者正在積極尋求與其他公司的收購和合資企業,以鞏固其在全球的市場地位。 目前主導市場的公司包括 Amphenol Corporation、Smiths Interconnect、TE Con□□nectivity、Fischer Connectors SA 和 Molex, LLC。
The medical connector market is projected to register a CAGR of 10.3% during the forecast period.
As the number of COVID-19 patients and hospital admissions surged during the pandemic due to COVID-19 infection, the COVID-19 pandemic significantly expanded the use of healthcare-connected devices. Additionally, diminished production capacity and a slow supply chain impeded market growth in early 2020. According to a press release in February 2020, Amphenol Corp., a provider of connectors, reported that the COVID-19 outbreak in China impacted its business. Amphenol stated that the company does not expect to achieve its first-quarter sales target for 2020. Nevertheless, since the restrictions were lifted, the industry has recovered successfully, and during the projection period, the supply chain has returned to normal.
The major factors contributing to the growth of the medical connectors market are the rising incidence of chronic diseases such as autoimmune diseases, cancer, blood disorders, and others. The rise in the population suffering from chronic diseases is also propelling the demand for these medical connectors. According to GLOBOCAN 2020, there were 19,292,789 new cancer cases worldwide in 2020 and 9,958,133 cancer-related deaths. Among all cancers, breast cancer accounted for 2,261,419 new cancer cases, followed by lung 2,206,771, prostate 1,414,259, and colon 1,148,515 new cases in 2020. Thus, the growing prevalence of chronic diseases is expected to boost the market for medical connectors during the forecast period.
Furthermore, a few key factors play crucial roles in taking the medical connectors market to the next level. These factors include technological advancement and medical connector developments, which are expected to propel the medical connector market growth. For instance, in September 2021, CPC (Colder Products Company), a Dover company that manufactures a wide range of single-use connectors, introduced a new ultra-compact sterile connector that provides biopharmaceutical manufacturers with a much-needed alternative to tube welding for their small-volume closed aseptic processes. MicroCNX Series Connectors are the first aseptic connectors in the market, developed to provide a simple, efficient manner of connecting tubing in small-format assemblies.
Thus, all the above-mentioned factors are expected to boost the market during the forecast period. However, stringent regulatory standards may restrain the market growth during the forecast period.
During minor and major procedures, patient monitoring devices are used to monitor a patient's clinical symptoms and related complications. In addition, these devices can be used to track patients' physiological data via advances in wireless technology. Rising incidence and prevalence of chronic diseases are expected to drive segment growth. Such instruments are a crucial part of various healthcare facilities, as they are designed to help physicians assess a disease's severity. Based on the article published in Circulation Research in May 2021, in France, over one million people were affected by heart failure (HF) in 2020 and there were more than 150,000 hospitalizations despite well-defined treatment management. Thus, the growing prevalence of chronic diseases is expected to boost segment growth during the forecast period.
In addition, increasing product approvals are expected to boost the market during the forecast period. For instance, in August 2022, Dozee and Midmark India, a South Asian producer of hospital beds and ancillary furniture with a strong presence in the nation, collaborated to develop India's first connected bed platform, which would automate and integrate patient monitoring in hospital beds, primarily in non-ICU settings.
Thus, all the aforementioned factors are expected to boost segment growth during the forecast period.
North America is expected to dominate the overall medical connectors market during the forecast period. This is owing to factors such as the rising incidence of chronic diseases such as cancer, blood disorders, autoimmune diseases, and other diseases. In addition, the availability of advanced healthcare infrastructure is one of the major factors. In the North American region, the United States holds the largest market share owing to factors such as the increasing population suffering from cancer. In addition, product launches by market players. For instance, according to the Canadian Cancer Society's 2021 report, about 229,200 new cancer cases were expected in Canada in 2021. On average, 628 Canadians are diagnosed with cancer every day, which is further expected to increase in the future. Lung, breast, colorectal, and prostate cancers are the most common types of cancer in Canada (excluding non-melanoma skin cancer). Thus, the growing prevalence of chronic diseases in the region is likely to support the growth of the market.
Additionally, product launches by the market players are expected to boost the market growth. For instance, in October 2022, Binder USA launched the Series 570 Easy Locking Connector (ELC), designed to meet the specific electromechanical connectivity requirements for use in medical devices. Biocompatible, non-irritating to skin, and resistant to disinfectants, this connector is ideal for usage in the patient environment.
Therefore, owing to the above-mentioned factors, the North American region is expected to register growth during the forecast period.
The medical connectors market is moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions across the globe. Some of the companies that are currently dominating the market are Amphenol Corporation, Smiths Interconnect, TE Connectivity, Fischer Connectors SA, and Molex, LLC